<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR30">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dimopoulos</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Delforge</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Hajek</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Kropff</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Petrucci</surname>
    <given-names>MT</given-names>
   </name>
   <name>
    <surname>Lewis</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Nixon</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Mei</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Palumbo</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial</article-title>
  <source>Haematologica</source>
  <year>2013</year>
  <volume>98</volume>
  <issue>5</issue>
  <fpage>784</fpage>
  <lpage>788</lpage>
  <pub-id pub-id-type="doi">10.3324/haematol.2012.074534</pub-id>
  <?supplied-pmid 23242595?>
  <pub-id pub-id-type="pmid">23242595</pub-id>
 </element-citation>
</ref>
